Unveiling the Future: Biologics Market to USD Value 412 billion in 2024, forecast by 2030, Featuring a CAGR of 8.25%

Global Biologics Market: In-Depth Analysis and Forecasts for 2024-2030

MarkNtel Advisors, a leading market research firm, has showed its latest study titled "Biologics Market", offering a detailed industry overview and market perspective. This comprehensive research provides insights into the current state of the market, highlighting recent advancements and emerging trends.

The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.

Analysis and Insights into the Biologics Market: 2024-2030

The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer's, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.

Request Free Sample of the Report - https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

What are the primary factors driving the growth of the Biologics Market?

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Biologics Market Segmentation:

The Biologics market is categorized in to different segments. Analyzing growth across these segments enables a comprehensive understanding of key growth areas within the industry. This segmentation provides valuable market insights, empowering stakeholders to make strategic decisions and identify primary market applications effectively.

By Therapeutic Application

Oncology- Market Size & Forecast 2019-2030, (USD Million)
Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
Diabetes- Market Size & Forecast 2019-2030, (USD Million)
Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
- Hormones- Market Size & Forecast 2019-2030, (USD Million)
- Cytokines- Market Size & Forecast 2019-2030, (USD Million)
Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
Vaccines- Market Size & Forecast 2019-2030, (USD Million)
Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

Microbes- Market Size & Forecast 2019-2030, (USD Million)
Humans- Market Size & Forecast 2019-2030, (USD Million)
Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million)

Geographical Analysis into the Biologics Market:

The Biologics market is categorized based regional:

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

View Full Report [Including Description + TOC] - https://www.marknteladvisors.com/research-library/global-biologics-market.html

Competitive Landscape and Biologics Market Share Analysis:

The competitive landscape of the Biologics Market includes comprehensive details about competitors. These details encompass company overviews, financial performance, revenue generation, market potential, investments in research and development, new market strategies, production facilities, strengths and weaknesses, product launches, ongoing trials, approvals, patents, product range, dominant applications, and technology life cycle.

Bristol-Myers Squibb
Pfizer
Sanofi
Janssen Biotech, Inc.
Bayer AG
Merck & Co.
Amgen Inc.
Abbott GmbH
Novartis
AstraZeneca Plc
GlaxoSmithKline Biologicals
Moderna, Inc.
Ferring Pharmaceuticals Inc.
Aimmune Therapeutics, Inc.
Hoffman La Roche

Sent Customized Report Inquiry - https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

What factors are driving the Biologics Market growth?
How is the Biologics Market expected to grow over the next five years?
What are the key insights into the current trends in the Biologics Market?
What is the current size of the Biologics Market, and how is it projected to change in the future?
What is the future outlook for the Biologics Market in terms of technological advancements and market expansion?

Why choose MarkNtel?

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.